Adverum Biotechnologies, Inc. Intellectual Property Contracts & Agreements
12 Contracts & Agreements
- License Agreements (12 contracts)
- License Agreement, between the Company and Virovek, Inc. (Virovek), dated October 12, 2011 (the Virovek License) (Filed With SEC on March 6, 2019)
- Exclusive License Agreement, between the Company and the Regents of the University of California (UC), dated June 17, 2013 (the UC License) (Filed With SEC on March 6, 2019)
- AMENDMENT N1 TO LICENSE AGREEMENT N12364A10 (Filed With SEC on August 9, 2016)
- LICENSE AGREEMENT (Filed With SEC on August 9, 2016)
- LICENSE AGREEMENT (Filed With SEC on August 9, 2016)
- License Agreement (Filed With SEC on August 9, 2016)
- LICENSE AGREEMENT BETWEEN ANNAPURNA THERAPEUTICS LIMITED AND CORNELL UNIVERSITY FOR [***] CTL CONTRACT NO. C2016-11-10548 TABLE OF CONTENTS (Filed With SEC on August 9, 2016)
- LICENSE AGREEMENT BETWEEN ANNAPURNA THERAPEUTICS LIMITED AND CORNELL UNIVERSITY FOR [***] CTL CONTRACT NO. C2016-11-10547 TABLE OF CONTENTS (Filed With SEC on August 9, 2016)
- LICENSE AGREEMENT BETWEEN ANNAPURNA THERAPEUTICS LIMITED AND CORNELL UNIVERSITY FOR [***] CTL CONTRACT NO. C2016-11-10546 (Filed With SEC on August 9, 2016)
- EXCLUSIVE LICENSE BETWEEN AVALANCHEBIOTECHNOLOGIES, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR USE OF RECOMBINANTGENE DELIVERY VECTORS FOR TREATING OR PREVENTING... (Filed With SEC on July 29, 2014)
- AMENDMENT # 1 TO: EXCLUSIVE LICENSE AGREEMENT FOR USE OF RECOMBINANTGENE DELIVERY VECTORS FOR TREATING OR PREVENTING DISEASES OF THE EYE UC Case No.: [***] (Filed With SEC on June 30, 2014)
- EXCLUSIVE LICENSE BETWEEN AVALANCHEBIOTECHNOLOGIES, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR USE OF RECOMBINANTGENE DELIVERY VECTORS FOR TREATING OR PREVENTING... (Filed With SEC on June 30, 2014)
